Suppr超能文献

急性躁狂症治疗患者缓解时间和复发的预测因素:躁狂发作的健康结局(HOME)研究

Predictive factors for time to remission and recurrence in patients treated for acute mania: health outcomes of manic episodes (HOME) study.

作者信息

Kora Kaan, Saylan Mete, Akkaya Cengiz, Karamustafalioglu Nesrin, Tomruk Nesrin, Yasan Aziz, Oral Timucin

机构信息

Department of Psychiatry, Marmara University, Istanbul, Turkey.

出版信息

Prim Care Companion J Clin Psychiatry. 2008;10(2):114-9. doi: 10.4088/pcc.v10n0205.

Abstract

OBJECTIVE

To determine the time to remission and recurrence in patients treated for acute mania and the predictive factors associated with these outcomes.

METHOD

This observational study, conducted in Turkey from April 2003 to January 2005, included patients with a DSM-IV diagnosis of bipolar I disorder, acute manic or mixed episode who were eligible to have an oral medication initiated or changed for the treatment of the episode. The patients were followed-up for 12 months.

RESULTS

A total of 584 patients (mean ± SD age = 33.9 ± 11.2, 55.2% outpatients) were enrolled in 53 centers. Eighty-five percent of patients had a manic episode at baseline, with a mean ± SD duration of 21.6 ± 24.4 days. The baseline mean ± SD Clinical Global Impressions scale for use in bipolar disorder and Young Mania Rating Scale (YMRS) scores were 4.9 ± 0.9 (median = 5.0) and 33.2 ± 9.3 (median = 33), respectively. 539 patients achieved remission and, of those, 141 patients had recurrence. One-year remission and recurrence rates were 99.0% and 35.7%, respectively. Mean ± SD times to remission and recurrence in descriptive statistics were 80.9 ± 73.8 (median = 50) and 159.0 ± 95.5 (median = 156) days, respectively. In Cox regression analysis, psychiatric comorbidities (p = .048), a higher YMRS score (p < .001), and a higher number of previous depressive episodes (p = .009) were statistically significant predictors of a longer time to reach remission. Index episodes of longer duration (p = .033) and mixed type (p = 0.49) were significant predictors of a shorter time to recurrence. Confounding factors like concomitant treatment, comorbidities, and lack of blinding and randomization were other limitations.

CONCLUSION

Predictors for a longer time to remission were psychiatric comorbidities, a higher YMRS score, and a higher number of previous depressive episodes. Predictors for a shorter time to recurrence were episodes of longer duration and mixed type.

摘要

目的

确定接受急性躁狂治疗的患者达到缓解和复发的时间,以及与这些结局相关的预测因素。

方法

这项观察性研究于2003年4月至2005年1月在土耳其进行,纳入了符合DSM-IV双相I型障碍、急性躁狂或混合发作诊断标准且有资格开始或更改口服药物治疗该发作的患者。对患者进行了12个月的随访。

结果

共有584名患者(平均±标准差年龄 = 33.9 ± 11.2岁,55.2%为门诊患者)在53个中心入组。85%的患者在基线时有躁狂发作,平均±标准差持续时间为21.6 ± 24.4天。用于双相情感障碍的基线平均±标准差临床总体印象量表和青年躁狂评定量表(YMRS)评分分别为4.9 ± 0.9(中位数 = 5.0)和33.2 ± 9.3(中位数 = 33)。539名患者实现缓解,其中141名患者复发。一年缓解率和复发率分别为99.0%和35.7%。描述性统计中达到缓解和复发的平均±标准差时间分别为80.9 ± 73.8(中位数 = 50)天和159.0 ± 95.5(中位数 = 156)天。在Cox回归分析中,精神科合并症(p = 0.048)、较高的YMRS评分(p < 0.001)以及既往抑郁发作次数较多(p = 0.009)是达到缓解时间较长的统计学显著预测因素。发作持续时间较长(p = 0.033)和混合型(p = 0.49)是复发时间较短的显著预测因素。诸如联合治疗、合并症以及缺乏盲法和随机化等混杂因素是其他局限性。

结论

缓解时间较长的预测因素是精神科合并症、较高的YMRS评分以及既往抑郁发作次数较多。复发时间较短的预测因素是发作持续时间较长和混合型发作。

相似文献

4
[Antipsychotics in bipolar disorders].[双相情感障碍中的抗精神病药物]
Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5.

本文引用的文献

1
Polytherapy in bipolar disorder.双相情感障碍的联合治疗
CNS Drugs. 2006;20(1):29-42. doi: 10.2165/00023210-200620010-00003.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验